Stem cells for severe lung injury from sepsis
Part of Lungs & breathing clinical trials.
This trial tests if adding stem cells or their growth liquid to standard sepsis treatment helps adults with severe breathing problems. It may improve recovery for those whose family agrees to the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older
- You have severe breathing failure (called ARDS) from sepsis
- Your family must agree to the study rules and not join other trials during this time
- You are not pregnant (for women)
- Your liver tests (SGOT/SGPT) are not very high (less than 5 times normal)
- Your kidneys work well enough (eGFR at least 30 ml/min) and you are not on dialysis
- You do not have more than 2 other serious health problems like diabetes, heart disease, or cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stem cell treatment made from umbilical cord cells for people with ARDS, a serious lung condition. The treatment may help reduce inflammation and improve lung function.
This trial tests a new treatment using stem cells from umbilical cords, given through an IV, for people with severe ARDS. The goal is to see if it's safe and helps improve breathing.
This trial tests a treatment made from human umbilical cord stem cells for people with moderate ARDS. The goal is to see if it is safe and well-tolerated, and if it might help the lungs recover faster.
This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
This trial tests a treatment made from human umbilical cord cells to help the body fight severe infections (sepsis). It might reduce inflammation and improve recovery.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.